Dr LAU Kui Kai, Gary

Dr Gary Lau

Clinical Associate Professor
Director of Educational Technology
Deputy Director of MBBS Admissions

  • MBBS (HK), MRes (Med) (HK), MRCP (UK), DPhil (Oxon), AFHEA (UK), FHKCP, FHKAM (Medicine), FRCP (Edin, Glasg), FESO
Biography

Gary Kui Kai Lau graduated in 2008 from the University of Hong Kong with a MBBS and Master of Research in Cardiovascular Medicine degree. He joined the Division of Neurology, University of Hong Kong as Clinical Assistant Professor in 2011 under the prestigious Young Academic Scheme. He completed his Neurology training at Queen Mary Hospital in 2015 and subsequently received a PhD in Clinical Neurosciences (Stroke medicine) in 2018 (University of Oxford Croucher Scholar) at The Centre for Prevention of Stroke and Dementia, University of Oxford, under the mentorship of Professor Peter Rothwell. He was promoted to Clinical Associate Professor in 2022.

Dr Lau’s research focuses on the causes of stroke and improving the prevention of stroke. He has published over 130 research articles or book chapters relating to stroke, including in reputable journals such as Lancet Neurology, Lancet Infectious Diseases, European Heart Journal, Nature Communications, JAMA Neurology, Neurology and Stroke. He currently leads the Stroke Research and Prevention Group, and is the Principal Investigator / Co-Principal Investigator of four prospective stroke registries in different regions of Hong Kong. He pioneered the WeRISE App – a one-stop platform for stroke patients and families combating stroke. This App has been widely utilised and disseminated throughout the medical and social sectors of Hong Kong.

Dr Lau is a recognised regional leader in stroke and is a Founding Steering Committee Member of the Microbleeds International Collaborative Network (MICON), Steering Committee Member and Country Lead of the International Multicentre Patent Foramen Ovale and Stroke registry (IMPROVE) and Founding Committee Member of the Neurological and Mental Health Global Epidemiology Network (NeuroGEN). He is a Director of the Hong Kong Stroke Fund, Honorary Treasurer of the Hong Kong Stroke Society, and currently serves as an Honorary Advisor for the Hong Kong Stroke Association and Hong Kong Society for Rehabilitation.

Dr Lau has also made substantial contributions to teaching and learning, in particular relating to innovative pedagogies in eLearning. He is currently the Director of Educational Technology at HKUMed, is the Founding Editor of the HKU eLearning Platform in Clinical Neurosciences and was the Chief Coordinator of the HKU eLearning Platform in Clinical Medicine.

In recognition of his clinical, research and teaching excellence, Dr Lau has been awarded the Paul Dudley White International Scholar Award, American Heart Association Award for Patient-Oriented or Clinical Research in Hypertension, Hong Kong West Cluster Outstanding Team Award for Comprehensive Acute Stroke Service; Faculty Teaching Medal, British Medical Association Medical Book Award and Smart Ageing Award (Gold Award).

ORCID: https://orcid.org/0000-0002-8657-2418


Selected Publications
  1. Lau KK, Li L, Schulz U, Simoni M, Chan KH, Ho SL, Cheung RTF, Kuker W, Mak HKF, Rothwell PM. Total Small Vessel Disease Score and risk of recurrent stroke – validation in two large cohorts. Neurology 2017; 88: 2260-2267 (Impact factor 11.800)
  2. Teo KC, Leung WCY, Wong YK, Liu RKC, Chan AHY, Choi OMY, Kwok WM, Leung KK, Tse MY, Cheung RTF, Tsang ACO, Lau KK (corresponding author). Delays in stroke onset to hospital arrival time during COVID-19. Stroke 2020; 51(7):2228-2231 (Impact factor 10.170)
  3. Lau KK, Lovelock CE, Li L, Simoni M, Gutnikov S, Kuker W, Mak HKF, Rothwell PM. Antiplatelet treatment after TIA and ischaemic stroke in patients with cerebral microbleeds in two large cohorts and an updated systematic review. Stroke 2018; 40(6):1434-1442. (Impact factor 10.170)
  4. Lau KK, Li L, Simoni M, Mehta Z, Kuker W, Rothwell PM. Long-term premorbid blood pressure and cerebral small vessel disease burden on imaging in TIA and ischaemic stroke: population-based study. Stroke 2018; 49(9): 2053-2060 (Impact factor 10.170)
  5. Lau KK, Li L, Lovelock CE, Zamboni G, Chan TT, Chiang MF, Lo KT, Kuker W, Mak HKF, Rothwell PM. Clinical correlates, ethnic differences and prognostic implications of perivascular spaces in TIA and ischaemic stroke. Stroke 2017; 48:1470-1477 (Impact factor 10.170)
  6. Lau KK, Wong YK, Teo KC, Chang RSK, Tse MY, Hoi CP, Chan CY, Chan OL, Cheung RHK, Wong EKM, Kwan JSK, Hui ES, Mak HKF. Long-term prognostic implications of cerebral microbleeds in Chinese with ischaemic stroke. Journal of American Heart Association 2017; 7;6(12). pii: e007360 (Impact factor 6.106)
  7. Lau KK, Chua BJ, Ng A, Leung IYH, Wong YK, Chan AHY, Chiu YK, Chu AXW, Leung WCY, Tsang ACO, Teo KC, Mak HKF. LDL-cholesterol and risk of recurrent vascular events in Chinese ischaemic stroke patients with and without significant atherosclerosis. Journal of the American Heart Association 2021 Aug 7; 10(16):e021855 (Impact factor 6.106)
  8. Lau KK, Pego P, Mazzucco S, Li L, Howard DPJ, Küker W, Rothwell PM. Age and sex-specific associations of carotid pulsatility with small vessel disease burden in transient ischaemic attack and ischaemic stroke. International Journal of Stroke 2018; 13(8): 832-839 (Impact factor 6.948)
  9. Lau KK, Wong YK, Chang RSK, Teo KC, Hon SFK, Chan KH, Wat KL, Cheung RTF, Li LSW, Siu CW, Ho SL and Tse HF. Visit-to-visit systolic blood pressure variability predicts all-cause and cardiovascular mortality after lacunar infarct. European Journal of Neurology 2014; 21(2): 319-25 (Impact factor 6.288)
  10. Lau KK, Wong YK, Chan YH, Yiu KH, Teo KC, Li LS, Ho SL, Chan KH, Siu CW and Tse HF. Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with type 2 diabetes. Cardiovascular Diabetology 2012; 11: 101 (Impact factor 8.949)

Awards
  • Paul Dudley White International Scholar Award, American Heart Association, 2022
  • Award for Patient-Oriented or Clinical Research in Hypertension, American Heart Association, 2022
  • Smart Ageing Award (Gold Award, “Social & Community Engagement” Category), Golden Age Foundation, 2021
  • British Medical Association Medical Book Award, 2019 (highly commended title under category ‘Neurology’)
  • Distinguished Research Paper Award for Young Investigators, Hong Kong College of Physicians, 2017 and 2018
  • Hong Kong West Cluster Outstanding Team (Comprehensive Acute Stroke Service), 2018
  • Faculty Teaching Medal, Li Ka Shing Faculty of Medicine, HKU, 2014
  • University of Oxford Croucher Scholarship, 2014

Grant Record
  • Health and Medical Research Fund, Hong Kong Government Food & Health Bureau, 2021 (PI)
  • Innovation and Technology Fund for Better Living, 2021 (co-project coordinator)
  • University Grants Committee Research Impact Fund, 2021 (co-PI)
  • RGC Collaborative Research Fund, 2021 (co-PI)
  • Health and Medical Research Fund, Hong Kong Government Food & Health Bureau, 2019 (PI)
  • Interdisciplinary Knowledge Exchange Project Fund, HKU, 2019 (PI)
  • Knowledge Exchange Impact Project Funding, HKU, 2014 (PI)
  • Faculty Development Fund in Development of Medical and Health Sciences Education, HKU, 2013 (PI)
  • Teaching Development Grant, HKU, 2013 (PI)

Books edited
  • Gary KK Lau, Sarah P Pendlebury and Peter M Rothwell. Transient Ischaemic Attack and Stroke: Diagnosis, Investigation and Management (2nd edition). Cambridge University Press 2018 (32 chapters, 502 pages)

Key Offices
  • Associate Editor, Frontiers in Neurology (Stroke Section)
  • Director, Hong Kong Stroke Fund
  • Honorary Treasurer, Hong Kong Stroke Society
  • Honorary Advisor, Hong Kong Stroke Association
  • Honorary Advisor, Hong Kong Society for Rehabilitation
  • Director of Educational Technology, LKS Faculty of Medicine, HKU
  • Convenor, Intercalation Unit, Enrichment Year Subcommittee, LKS Faculty of Medicine, HKU
  • Deputy Director of Admissions, MBBS Admissions Working Group, School of Clinical Medicine, LKS Faculty of Medicine, HKU